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Background: The successful pneumococcal clone 
Spain9V-ST156 (PMEN3) is usually associated with 
vaccine serotypes 9V and 14. Aim: Our objective was 
to analyse the increase of a serotype 11A variant of 
PMEN3 as cause of invasive pneumococcal disease 
(IPD) in Spain and its spread in south-western Europe.
Methods: We conducted a prospective multicentre 
study of adult IPD in Spain (2008–16). Furthermore, a 
subset of 61 penicillin-resistant serotype 11A isolates 
from France, Italy, Portugal and Spain were subjected 
to whole genome sequencing (WGS) and compared 
with 238 genomes from the European Nucleotide 
Archive (ENA). Results: Although the incidence of 
serotype 11A in IPD was stable, a clonal shift was 
detected from CC62 (penicillin-susceptible) to CC156 
(penicillin-resistant). By WGS, three major 11A-CC156 
lineages were identified, linked to ST156 (n = 5 iso-
lates; France, Italy and Portugal), ST166 (n = 4 isolates; 
France and Portugal) and ST838/6521 (n = 52 isolates; 
France, Portugal and Spain). Acquisition of the 11A 
capsule allowed to escape vaccine effect. AP200 (11A-
ST62) was the donor for ST156 and ST838/6521 but 
not for ST166. In-depth analysis of ST838/6521 line-
age showed two multi-fragment recombination events 
including four and seven fragments from an 11A-ST62 
and an NT-ST344 representative, respectively.
Conclusion: The increase in penicillin-resistant sero-
type 11A IPD in Spain was linked to the spread of a 
vaccine escape PMEN3 recombinant clone. Several 
recombination events were observed in PMEN3 acquir-
ing an 11A capsule. The most successful 11A-PMEN3 
lineage spreading in south-western Europe appeared 
after two multi-fragment recombination events with 
representatives of two major pneumococcal clones 
(11A-ST62 and NT-ST344).
Introduction
Streptococcus pneumoniae  is an important human 
pathogen that usually colonises the upper respiratory 
tract. Pneumococci can invade sterile sites causing 
different invasive pneumococcal diseases (IPD) such 
as bacteraemic pneumonia, meningitis or primary 
bacteraemia. Furthermore, pneumococci cause other 
non-invasive diseases such as acute otitis media in 
children or acute exacerbations of COPD in adults 
[1,2]. The polysaccharide capsule, which presents one 
of more than 97 serotypes, is the main virulence fac-
tor and its diversity has been associated with differ-
ences in invasiveness and mortality. Pneumococcal 
conjugated vaccines (PCV) include the serotypes more 
commonly found among IPD. In Spain, three conjugate 
vaccines had been licensed: the first one in 2001, 
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PCV7, targeted serotypes 4, 6B, 9V, 14, 18C, 19F and 
23F; the second in 2009, PCV10, added serotypes 1, 
5 and 7F and PCV13 in 2010 added serotypes 3, 6A 
and 19A [3]. The natural ability of  S. pneumoniae  to 
undergo genetic transformation allows pneumococci to 
change the capsule (capsular switching) which allows 
them to escape vaccine pressure. The emergence 
of new recombinant clones along with serotype 
replacement has changed the serotype distribution 
after the introduction of paediatric vaccination [4,5]. 
Among them, an increase in serotype 11A, not included 
in PCV13, has been reported worldwide [1,4,6,7]. Many 
studies suggest that serotype 11A has a low invasive 
potential [5] being present mainly in child carriers [8] 
and patients with chronic obstructive pulmonary dis-
ease (COPD) [9]. Serotype 11A has classically been 
linked to the antibiotic-susceptible lineage CC62 [10], 
with the exception of some macrolide-resistant isolates 
with the M phenotype (resistance to 14- and 15-mem-
bered ring macrolides) [11]. In 2005, the emergence of 
a penicillin- and amoxicillin-resistant serotype 11A line-
age related to CC156 was identified [10]. In our setting, 
serotype 11A isolates related to the CC156 clone were 
the leading cause of β-lactam resistance in the years 
2015 and 2016 [12]. Nowadays, in Spain, there are two 
main serotype 11A sequence types (ST) derived from 
CC156: ST838, first detected in 2005, which is a sin-
gle locus variant (SLV) of ST156; and ST6521 which is 
a double locus variant (DLV) of ST156 emerged in 2009 
[10]. These STs are related to clonal complex CC156 
also known as the Spain9V-ST156 clone (PMEN3). This 
clone, originally associated with serotype 9V, has been 
related to capsular switching since the 1990s when the 
acquisition of the capsule 14 led to a worldwide spread 
of this serotype. In fact, most of serotype 14 isolates 
causing IPD in the pre-PCV era were related to the 
PMEN3 recombinant lineage [13,14]. Besides serotype 
14, PMEN3 recombined with other serotypes showing a 
high capacity to exchange the capsular locus, resulting 
in the evasion of the vaccine effects [15].
In this study, we firstly studied the increase of β-lactam-
resistant serotype 11A pneumococci as the cause of 
adult IPD in the framework of a multicentre study in 
Figure 1
Total and pneumococcal serotype 11A cases, associated clonal complex and resistance, south-western Europe, 2008-2016 
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Amox: amoxicillin; CC: clonal complex; IPD: invasive pneumococcal disease; MIC: minimum inhibitory concentration; Pen: penicillin; R: 
resistance; S: susceptible; ST: sequence type.
The recombinant clone ST6521-serotype 11A is spreading in Europe.
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Spain. Secondly, using whole genome sequencing 
(WGS), we analysed the spread of the recombinant 
clone S11A-ST6521 including neighbouring countries in 
south-western Europe which also detected penicillin-
resistant serotype 11A isolates.
Methods
Study design and bacterial characterisation
This study was initially conducted in the framework of a 
laboratory-based multicentre study of adult (≥ 18 years-
old) IPD patients, involving six Spanish hospitals. An 
IPD episode was defined as the isolation of  S. pneu-
moniae from a normally sterile body fluid and only one 
isolate per episode was included [16]. We included IPD 
episodes caused by serotype 11A from 2008 to 2016.
Serotyping by dot blot assay or Quellung reaction 
was done at the Spanish Reference Laboratory for 
Pneumococci (SRLP). The antibiotic susceptibility to 
seven antimicrobials (amoxicillin, cefotaxime, cotri-
moxazole, erythromycin, levofloxacin, penicillin and 
tetracycline) was tested by microdilution following the 
European Committee on Antimicrobial Susceptibility 
Testing (EUCAST) guidelines [17]. Genotyping was per-
formed by pulse field gel electrophoresis (PFGE) and/
or multilocus sequence typing (MLST) as described 
previously [18,19].
Whole-genome sequencing and assembly
To evaluate the spread of the serotype 11A multidrug-
resistant clone, a total of 61 penicillin-resistant (≥ 0.12 
mg/L) serotype 11A isolates were selected for WGS. Of 
these, 21 were collected from the multicentre study 
and the remaining 40 were obtained from the Reference 
Laboratory for Pneumococci or Pneumococcal 
Reference Groups from France (n = 17), Italy (n = 4), 
Portugal (n = 4) and Spain (n = 16). Metadata including 
demographic characteristics, WGS-derived data and 
antibiotic minimum inhibitory concentrations (MIC) are 
summarised in  Supplementary Table S1. A diagram of 
the study design and a flowchart of the bioinformatic 
analysis are also summarised in Supplementary Figure 
S1.
Figure 2
Capsular switching and recombination breakpoints, pneumococcal isolates, south-western Europe























































BLAST: basic local alignment search tool; ENA: European Nucleotide Archive; MLST: multilocus sequence typing; NCBI: National Center for 
Biotechnology Information; SNP: single nucleotide polymorphism; ST: sequence type.
Panel A: The maximum likelihood phylogenetic tree includes the 61 sequenced strains and 238 strains of serotypes 9V and 11A for which 
genomes were available in ENA and which belonged to ST related to CC156 (ST156, ST166, ST838 or ST6521). The colour of each circle 
represents different characteristics of the strains. Outer circle: lineages; middle circle: ST; inner circle: serotypes.
Panel B: The analysis of the capsular operon was done with 61 genomes from this study and a selection of 59 from the 238 ENA genomes. 
The different structures are numbered I to VIII. Colours are related to the closest fully closed genome on NCBI (indicated in the legend with 
serotype and MLST). Black regions: areas with identity < 95% with NCBI fully closed genomes after BLAST search; pink squares: non-analysed 
flanking transposases.
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Bacteria were grown overnight in 5% sheep blood 
agar at 37ᵒC + 5% CO2. DNA was extracted using the 
QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) 
and quantified using the QuantiFluor dsDNA System 
(Promega, Wisconsin, United States (US)). Illumina 
paired-end libraries (2 × 150 bp) were prepared with 
the Nextera XT kit and sequenced on Illumina MiSeq 
Platform (Illumina Inc., San Diego, US). Read quality 
assessment and genome assembly was done using 
the INNUca v3.2 pipeline (https://github.com/B-UMMI/
INNUca) through ummidock/innuca:3.2–01. Firstly, 
a quality control of the reads was performed using 
FastQC v0.11.5 (http://www.bioinformatics.babraham.
ac.uk/projects/fastqc/) and reads were cleaned and 
trimmed with Trimmomatic v0.36 [20]. The genome was 
assembled using SPAdes v3.11.0 [21] and subsequently 
polished using Pilon v1.18 [22]. The in silico MLST was 
determined using Seemann’s MLST v2.11 (https://
github.com/tseemann/mlst). The final assemblies were 
annotated by Prokka v.1.12 [23] through ummidock/
prokka:1.12 Docker image. Reads were deposited at 
the European Nucleotide Archive (ENA) with accession 
numbers summarised in Supplementary Table S1.
Comparative analysis by whole genome 
sequencing
Molecular antibiotic resistance mechanisms
The in silico analysis of gene mutations involved in 
antibiotic resistance (pbp1a, pbp2x, pbp2b, parC, 
parE, gyrA, folA  and  folP) was done manually using 
Geneious R9 (Biomatters, Auckland, New Zealand) 
and the R6 genome (NC_003098) as reference. The 
acquired resistance mechanisms were screened using 
Abricate v0.8.0 (https://github.com/tseemann/abri-
cate) through flowcraft/abricate:0.8.0–3 Docker image 
for the Comprehensive Antibiotic Resistance Database 
(CARD) [24] and ResFinder [25] databases.
Phylogenetic analysis
To better explore the diversity and relationship with 
other pneumococci with related serotype and ST to the 
penicillin-resistant 11A isolates included in this study, 
47,529 available S. pneumoniae genomes deposited in 
ENA were downloaded on 29 October 2018 using get-
SeqENA v1.3 (https://github.com/B-UMMI/getSeqENA) 
with Aspera Connect v3.7.2.141527 (https://aspera-
soft.com/software/clients/connect/). In case of large 
fastq file sizes, they were first downsampled for an 
estimated depth of coverage of 100 × with the sam-
ple_fastq script commit 01ac0db available at  https://
github.com/jacarrico/sample_fastq  and making use 
of Seqtk v1.2-r94, (https://github.com/lh3/seqtk). The 
serotype was in silico deduced using Seroba v1.0.1 [26]. 
Among the 47,529 available genomes, we selected 238 
with serotypes 9V or 11A and with one of the following 
MLST: ST156, ST166, ST838 or ST6521 (Supplementary 
Table S2). Phylogenetic analysis was performed by 
constructing an assembly-based core genome-single 
nucleotide polymorphism (SNP) phylogenetic tree with 
the default parameters of  Parsnp  from the Harvest 
suite [27] with the exception of parameter ‘x’ which 
identifies and removes recent recombination using 
PhilPack [28]. Isolate ERR2681167 was used as refer-
ence. Phylogenetic tree visualisation was done using 
Microreact [29].
Capsular operon analysis
Three contiguous regions were analysed: region 1 
(pbp2x to dexB), region 2 (capsular locus) and region 3 
(aliA to pbp1a). Because the capsular operon is flanked 
by transposases, which are difficult to assemble 
using the small reads generated by Illumina method-
ology, these regions were located in different contigs, 
so it was not possible to analyse the whole region 
from pbp2x to pbp1a. A BLASTn search on the National 
Center for Biotechnology (NCBI) website (https://blast.
ncbi.nlm.nih.gov/Blast.cgi) was performed to deter-
mine which deposited fully closed genome presented 
the highest identity with the isolates included in the 
study. In addition, region 2 was compared with refer-
ence capsular operons (1813/39–11A (CR931653) and 
980/60–9V (CR931648)) previously described [30].
Identification of recombination regions
To determine the genomic differences between ST838 
and ST6521 isolates, a maximum-likelihood phyloge-
netic tree was constructed with the 68 isolates belong-
ing to these two ST, 52 from this study and 16 from ENA, 
using RaxML [31]. The 9V-ST838 (ERR2303060) draft 
assembled genome was concatenated by mapping the 
contigs against 4041STDY6836167 (NZ_LS483448), 
which is a closed serotype 9V, ST156 genome using 
Mauve [32]. The 9V-ST838 concatenated genome was 
used as a reference and the 68 reads belonging to line-
age 3 isolates were mapped using Snippy 3.1 (https://
github.com/tseemann/snippy). An assembly-free core-
SNP alignment was done with Snippy’s core module 
(snippy-core). The alignment was used to identify the 
recombinant regions through the evaluation of the 
density of base substitution using Gubbins v2.3.4 [33] 
and the results were visualised in Phandango [34]. The 
allelic variation of fragment exchange in recombina-
tion events were manually examined with Geneious R9 
and the highest identity with S. pneumoniae genomes 
available on NCBI was explored using BLASTn search 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi).
Core and accessory genome
The core genes, which are shared by all isolates, and 
accessory genes of the 68 isolates belonging to ST838 
and ST6521 were analysed using Roary v3.12.0 [35], 
with a minimum percentage identity of 80% for BLASTp. 
Identification of accessory genes segregating each ST 
was done by Scoary v1.16.16 [36].
Ethical statement
This project has been approved by the Clinical 
Research Ethics Committee of the Hospital de Bellvitge 
(PR153/18). Written informed consent was not required 
as this was an observational study with isolates 
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obtained as part of the normal microbiological routine. 
Patient confidentiality was always protected; all data 
were anonymised and protected according to national 
normative.
Results
A clonal shift has occurred among 
serotype 11A isolates causing adult invasive 
pneumococcal disease in Spain
Among 3,200 adult IPD episodes detected during the 
study period, 96 were caused by serotype 11A iso-
lates. We observed a non-significant increase in the 
incidence of serotype 11A IPD from 0.24 episodes per 
100,000 persons per year in 2008 to 0.36 episodes 
per 100,000 persons per year in 2016 (p = 0.22; inci-
dence risk ratio = 0.66; 95% confidence interval (CI): 
0.37–1.20). However, a clonal replacement linked to an 
increase in penicillin-resistant isolates was observed. 
While in 2008, no penicillin-resistant serotype 11A iso-
lates were detected, 11 of 13 IPD episodes due to sero-
type 11A were caused by penicillin-resistant isolates 
in 2016 (Figure 1). The PFGE/MLST analysis revealed 
two major clonal complexes: the penicillin-suscepti-
ble CC62 and the penicillin-resistant CC156. Isolates 
of CC62 were mostly antibiotic-susceptible (including 
to penicillin) except for several cotrimoxazole- (26 of 
44; 59.1%) or erythromycin-resistant (13 of 44; 29.5%) 
isolates. Macrolide resistance was due to the M pheno-
type, as previously described among CC62 isolates in 
Spain [11]. On the other hand, isolates of CC156 showed 
a common resistance pattern, being penicillin-resist-
ant (MIC range: 1–4 mg/L) and cotrimoxazole-resist-
ant (MIC range: 1/19 – >2/38 mg/L). Moreover, CC156 
isolates were mostly amoxicillin-resistant with a MIC 
range from 2 to 8 mg/L (Figure 1).
Figure 3
Analysis of recombination in lineage 3 (serotypes 9V and 11A), pneumococcal isolates, south-western Europe (n = 68)
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A. Phylogenetic incorporating serotype, ST and recombination events detected by Gubbins B. Multi-fragment recombination (1 to 7 and A to D) between 
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ST: sequence type.
Panel A. Green blocks: recombination segments for which putative donor is 11A-ST62 (AP200) and which are shared by strains of ST838, 
ST6521, ST14589 and ST14590; these blocks are labelled with capital letters (A to D). Red blocks: recombination segments which putative 
donor is NT-ST344 which are shared by strains ST6521, ST14589 and ST14590; these blocks are labelled with numbers (1 to 7). Grey blocks: 
recombination segments present in a single strain. Light blue blocks: recombination segments shared by small groups of strains.
Panel B. Dark blue: receptor 9V-ST838; green: putative receptor 11A-ST62; red: putative receptor NT-ST344. Coordinates refer to the ones of 
the genome of strain 4041STDY6836167. The approximate recombining fragment size is indicated.
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Whole genome sequencing of penicillin-resistant 
serotype 11A from south-western Europe
For an in-depth genomic analysis of penicillin-resistant 
serotype 11A isolates related to CC156, a collection of 
61 penicillin-resistant serotype 11A isolates isolated 
from patients with IPD in France, Italy, Portugal and 
Spain were subjected to WGS (Supplementary Figure 
S1). These isolates were recovered from 25 regions of 
the four European countries: France (n = 9), Italy (n = 2), 
Portugal (n = 3), and Spain (n = 11) (Supplementary 
Figure S2).
After in silico MLST analysis, six different ST were 
found: ST156, ST166 (SLV of 156), ST838 (SLV of 
ST156), ST6521 (SLV of ST838 and DLV of ST156), 
a new SLV of ST6521 (ST14589) and a new DLV of 
ST6521 (ST14590). Supplementary Figure S3 shows the 
phenotypic (MIC) and genotypic (resistome) profiles of 
the 11A-CC156 isolates and their association with the 
ST. The allelic profiles of their penicillin-binding pro-
teins (PBP) are described in  Supplementary Table S3, 
a name was assigned to each allele based on the pre-
vious definition by the US Centers for Disease Control 
and Prevention (CDC) [37,38]. The differences between 
ST in resistance to β-lactams were linked to changes 
in PBP. A common PBP1A allele (allele 15) identical 
to that of PMEN1 (American Type Culture Collection 
700669) was shared by all but three isolates (the lat-
ter presented allele 7 and a new allele (NEW1) close 
to allele 96 (96% identity)). We found the changes at 
the STMK373 motif (T371A allele 15 and T371S in allele 
NEW1) that had been previously described [15]. All but 
two isolates presenting allele 15, presented PBP2X 
allele 18 and a new allele (NEW1) related to allele 36 
(98.9% identity). Both alleles differed in only three 
amino acids and have the 337S A MK substitution. Two 
distinct PBP2B alleles were found segregating lineages 
ST156 and ST166 from ST838 and ST6521. All isolates 
presented the 443SSN  A  change in PBP2B. Moreover, 
isolates with allele 76 had an additional 10 changes 
between residues 590 and 641 related to increased 
amoxicillin MIC [15].
Macrolide-resistance was associated with the presence 
of integrative conjugative elements. All four ST166 
isolates carried the Tn6002  transposon (AY898750) 
described previously in  S. pneumoniae. This is a 
Tn916-like structure containing the tet(M) gene and the 
macrolide-aminoglycoside-streptothricin (MAS) ele-
ment  erm(B), conferring resistance to tetracycline and 
to erythromycin and clindamycin, macrolide-lincosa-
mide-streptogramin b (MLSB) phenotype, respectively. 
One 11A-ST6521 isolate carried a mobile element, 
the mef(E) gene in the macrolide efflux genetic assem-
bly (MEGA) element. All isolates were resistant to 
cotrimoxazole, a characteristic of the Spain9V-ST156 
(PMEN3) clone. All but one had the I100L amino acid 
substitution in the dihydrofolate reductase known to 
confer resistance to trimethoprim. In addition, all iso-
lates had a single insertion (S62SSY) or double insertion 
(S62SYSY; in ST166 isolates) in the dihydropteroate syn-
thase, known to confer resistance to sulfamethoxazole.
Different capsular switching events identified among 
the major serotype 11A lineages
Of the 238 selected genomes from ENA, 198 were sero-
type 9V (n = 183 ST156, n = 2 ST166 and n = 13 ST838) and 
the remaining 40 were serotype 11A (n = 5 ST156, n = 32 
ST166 and n = 3 ST6521). A phylogenetic tree was con-
structed using these 238 genomes and the 61 genomes 
of the present study (Figure 2A,  Supplementary Table 
S2). Three major lineages, including both 9V and 11A 
isolates, were defined including one or two closely 
related ST: lineage 1 (ST156), lineage 2 (ST166) and 
lineage 3 (ST838 and ST6521). To identify putative 
recombination events in the capsular locus we used all 
isolates, except in lineage 1, which accounted for the 
highest number of genomes (n = 188). In order to sim-
plify the analysis of the capsular switching event in this 
lineage we selected all five 11A-ST156 isolates from this 
study and the four phylogenetically closest 9V-ST156 
isolates (Supplementary Table S2).
The analysis of the capsular locus and the flank-
ing regions (region 1:  pbp2x-dexB; region 2: capsular 
locus; region 3:  aliA-pbp1a) in all lineages revealed 
eight different structures (numbered I to VIII;  Figure 
2B). Structure definition was based on per cent iden-
tity with complete genomes available in NCBI, where 
sequence stretches with identity lower than 95% were 
coloured in black. Among serotype 9V, three different 
structures were found (I, V and VI), the main differences 
among them were the region downstream of  pbp2x  in 
structures V and VI, and  pbp1a  in structure V. On the 
other hand, five different structures (II, III, IV, VII and 
VIII) were found among serotype 11A isolates. Two of 
them (II and III) were detected in lineage 1. Structure 
III presented different  pbp2x  and  pbp1a  genes and 
a different sequence in region 1, with high identity 
with the 4041STDY6836167 genome (NZ_LS483448), a 
serotype 7C-ST4956 isolate. All lineage 2 isolates had 
structure IV, which was closely related to that of an 11A 
isolate named strain11A (NZ_CP018838). However, the 
capsular locus (region 2) of structure IV had only 92% 
identity with the 11A capsule locus of the reference 
isolate 1813/39–11A [30]. Structure IV showed high 
identity (> 99%) with isolate PMP1342 (MF140334.1), 
a genetic variant of the 11A locus, with the exception 
of the  wzg  gene (identical to that of the 980/60–9V 
reference isolate). Finally, all but one of the lineage 3 
isolates shared structure VII. In this structure the DNA 
fragment integrated from AP200 (11A-ST62) included 
the capsular operon (region 2) and a portion of the 
region 3 but not the  pbp1A, which was similar to that 
of 4041STDY6836167, the 9V-ST156 isolate (Figure 2B). 
Structure VIII was found in a single isolate and differed 
from structure VII in the pbp1a gene. There were amino 
acid changes in some genes of the capsular locus in 
all structures which are summarised in Supplementary 
Table S4.
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Several results of recombination events are present in 
the successful 11A-ST6521 lineage
A scan for possible recombination events across the 
entire genome and identification of the possible donors 
was done with the 68 isolates of lineage 3, correspond-
ing to the most successful emerging penicillin-resistant 
serotype 11A isolates. Besides several possible recom-
binations identified among single isolates or minor 
clusters, we found two major recombination events 
(Figure 3). We considered as the donor the isolate 
which provided the capsule to the new recombinant 
isolate and as the recipient the isolate which incorpo-
rated the capsule sequence in its genetic background. 
The first recombination event involved a 9V-ST838 iso-
late as the recipient and a serotype 11A-ST62 isolate 
related to AP200 (NC_014494) as the donor. In this 
event, the capsule which allow to escape the vaccine 
effect (ca 16 kb, included in region A) and three addi-
tional regions (B–D) of the AP200-like isolate were 
incorporated into the 9V-ST838 genome (represented 
in green in Figure 3). Region A was a ca 50 kb recombi-
nation region which on closer analysis appeared to be 
discontinuous. This region included four segments of 
the AP200-like isolate (26 kb, 12 kb, 4.5 kb and 0.5 kb) 
interspersed with two small segments of the 9V-ST838 
isolate (2.5 kb and 4 kb), including the  pbp1a  gene. 
There was an additional 2 kb segment (between the 
12 kb and 4.5 kb segments of the AP200-like isolate) 
different from both isolates which could be charac-
teristic of the actual donor. Region A could therefore 
have resulted from a multi-fragment sequence integra-
tion. On the other hand, the recombination in the B, C 
and D regions incorporated fragments of ca 4 kb, 1.5 kb 
and 1.5 kb, respectively. A second multi-fragment 
recombination event possibly involved the recombi-
nant 11A-ST838 isolate as recipient and a representa-
tive of the worldwide disseminated non-typable ST344 
lineage (Figure 3). We identified seven fragments with 
high similarity to the NT-ST344 isolate NT_110_58 (NZ_
CP007593) in the recipient genome (11A-ST838). One of 
these fragments included the aroE gene, explaining the 
variation in the MLST profile. 
Allelic variation between ST838 and ST6521 in 
accessory genome and core genes
In a previous study, we showed different behaviours 
in evasion of host defenses and in biofilm formation 
between the two major ST of serotype 11A lineage 3 (11A-
ST838 and 11A-ST6521) [10]. In lineage 3, core genes 
represented around 70% of the total genes detected. 
Among the 1,707 core genes, the region A multi-frag-
ment recombination introduced 25 allelic variants into 
the recipient genome, in addition to the serotype 11A 
specific cps locus genes which are not part of the core 
genome. Furthermore, the second recombination event 
between 11A-ST838 and NT_110_58 incorporated 37 
allelic variants into the seven exchanged fragments 
differentiating 11A-ST6521 from 11A-ST838. Most of 
the core genes presented just one allele, while others 
presented two or more alleles. Most of the allelic 
differences among core genes did not segregate 
serotypes, ST or sub-lineages, with the exception of the 
allelic differences incorporated in the recombination 
events. The 62 allelic variations potentially introduced 
by recombination are summarised in  Supplementary 
Table S5. The analysis of the accessory genome per-
formed with Scoary revealed one gene that segregated 
ST6521 from ST838 (p < 0.01). This gene was a Gcn5-
related N-acetyltransferase (spnnt_RS02275) which 
was truncated in the ST838 isolates following to a sin-
gle nucleotide deletion.
Discussion
Current prevention of pneumococcal infections is based 
on vaccination and vaccines are serotype-dependent, 
offering protection against a subset of known sero-
types. Only 13 serotypes are included in the conjugate 
vaccine with the highest available valency, PCV13; 
its widespread use changed the worldwide serotype 
distribution [1]. During a multicentre study, a clonal 
replacement was observed among invasive pneumo-
cocci of serotype 11A (not included in PCV13), associ-
ated with the emergence of β-lactam resistance. This 
new lineage, related to Spain9V-ST156, was penicillin- 
and amoxicillin-resistant hampering the treatment of 
severe infections. Besides IPD, this amoxicillin-resist-
ant variant of serotype 11A has in Spain caused acute 
exacerbations of COPD patients [9] and otitis media in 
children [39], infections for which amoxicillin usually is 
the first-choice antibiotic therapy.
We analysed by WGS 61 isolates, from Spain and other 
south-western European countries where penicillin-
resistant 11A isolates have also been detected. Through 
this bioinformatic analysis, we tried to reconstruct the 
recent dynamics of the Spain9V-ST156 clone in south-
western Europe. We showed that the 11A-ST6521 lin-
eage was present in France, Portugal and Spain. Two 
additional 11A lineages (ST156 and ST166) were iden-
tified among French, Italian and Portuguese isolates. 
However, the β-lactam MIC were lower than those of 
ST838 and ST6521, in which high amoxicillin MIC are 
related to amino acid changes in the transpeptidase 
domain of PBP2B (residues 590–641), as described 
[15].
Two different recombinant structures were detected in 
lineage 1 (11A-ST156) for which we could not discard 
a common origin. Probably, there was a first recom-
bination with an AP200-like isolate, followed by a 
second recombination that incorporated a fragment 
between pbp2x and dexB which presents high identity 
with a 7C-ST1623 isolate. But this was not unequivo-
cally shown by our analysis. Moreover, a second line-
age (11A-ST166) was detected in France and Portugal, 
as well as in several isolates deposited in the ENA, 
showing yet different recombination events. This line-
age presented a variant of the serotype 11A capsular 
operon previously identified in Fiji [40]. The presence 
of a double insertion in the dihydropteroate synthase 
and the Tn6002 transposon carrying tet(M) and erm(B) 
was a hallmark of all four ST166 isolates suggesting 
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that another horizontal DNA transfer event was piv-
otal in conferring antimicrobial resistance to lineage 2 
(11A-ST166). Although the number of isolates included 
in the present work was low, the detection of this line-
age in France and Portugal and its multidrug resistance 
deserve further surveillance.
Another recombination event involved lineage 3 (11A-
ST838 giving rise to 11A-ST6521). Besides capsule and 
PBPs, other regions involving single isolates, minor or 
major clusters, accounted for the genetic diversity of 
this lineage. The presence of changes in a single iso-
late could suggest a patho-adaptative process in the 
course of invasive disease that was not enough to 
confer the ability to interpatient spread [41]. On the 
other hand, the presence of the same change in most 
isolates from the same ST suggests that it may have a 
beneficial fitness effect on their spread.
The careful analysis of ST838 and ST6521 serotype 
11A isolates identified two subsequent multi-fragment 
recombination events. The first one occurred between 
an AP200-like isolate [42] and a 9V-ST838. The major 
consequence of this recombination was the capsular 
switch that allowed this lineage to escape vaccine-
induced immunity. However, in a scenario of only vac-
cine pressure, a spread of 11A-ST62 could have been 
hypothesised. Therefore, it seems that the genetic 
characteristics of the Spain9V-ST156 clone such as the 
β-lactam resistance in an area with high-level antibi-
otic consumption were determinants for its success. 
Probably both vaccine and antibiotic pressure could 
favour this drift. Besides the capsular operon, three 
additional fragments from the putative AP200-like 
donor were integrated which may have resulted in still 
unidentified but important phenotypic changes. The 
second event occurred with an ST344 isolate, a non-
encapsulated worldwide disseminated clone identified 
in nasopharyngeal colonisation and non-invasive infec-
tions, particularly conjunctivitis [43,44]. In this recom-
bination, seven fragments of the ST344 representative 
were acquired by 11A-ST838. Although we could not 
exclude the possibility that these multi-fragment 
acquisitions occurred in different events from other 
pneumococci, our results strongly suggest that the two 
multi-fragment recombinations occurred with two iso-
lates related to AP200 and NT_110_58. The ability of 
PMEN3 to acquire multiple large genomic regions has 
been described previously, with a recombinant having 
acquired 5.3% of its genome from a PMEN1 represent-
ative [45]. Recently, it has been suggested that large 
recombination events are favoured in environments 
allowing stable cell-to-cell contact, such as colonisa-
tion or biofilm-associated infections [46]. Serotype 11A 
is currently a major serotype colonising children [7], 
and the serotype replacement in colonisation which 
occurred after PCV introduction could have favoured 
the widespread emergence of these 11A-PMEN3 vari-
ants. The incorporation of further genetic material 
from an ST344 representative could offer clues for 
the spread of 11A-ST6521. Among this acquired DNA, 
there are genes involved in biofilm formation, such 
as lytB [47]. Possibly, this second recombination could 
be behind the higher capacity to form biofilms and to 
evade the host immune system of the recombinant 11A-
ST6521 lineage which was previously described [10]. 
These traits can represent a patho-adaptive advantage 
of colonisation and also of causing biofilm-related dis-
eases such as otitis media or acute exacerbations of 
COPD [9,10], possibly contributing to the resilience of 
PMEN3 lineages as a cause of pneumococcal disease 
in the PCV era.
Conclusion
We describe a clonal shift among serotype 11A isolates 
causing IPD in Spain and the spread of a recombinant 
clone through different European countries. The first 
event allowed the β-lactam resistant clone to remain 
as cause of pneumococcal diseases and to escape the 
current vaccine. The second event gave adaptative 
advantages to cause disease. Probably both vaccine 
and antibiotic pressure could favour this drift. Further 
studies are needed to determine how much this line-
age has increased and what impact the multidrug 
resistance of this vaccine escape recombinant clone 
will have on the therapy of IPD and other pneumococ-
cal diseases in south-western Europe. Moreover, the 
ability of the Spain9V-ST156 clone to evolve, resulting in 
new recombinant lineages with new serotypes, implies 
a need to monitor this invasive clone and its possible 
drifts in the future.
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